BioArctic Eulerpool News

BioArctic Stock News

BioArctic is being monitored by journalists and investors worldwide. We gather the latest BioArctic news here.

• August 30 ·

  Yahoo
  US FDA approves Leqembi® IQKLIK™ (lecanemab-irmb) subcutaneous injection for maintenance dosing for the treatment of early Alzheimer's disease
• August 21 ·

  Yahoo
  Invitation to presentation of BioArctic's second quarter report for April - June 2025 on August 28 at 9.30 a.m. CET
• July 31 ·

  Yahoo
  BioArtic: Latest data presented at AAIC 2025 reinforces lecanemab's clinical effect with consistent safety profile
• July 16 ·

  Yahoo
  The drug discovery research for lecanemab awarded the 9th Bioindustry Award by the Japan Bioindustry Association
• June 2 ·

  Yahoo
  BioArctic's Capital Markets Day 2025 - entering a new era of growth
• May 15 ·

  Yahoo
  Eisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025 (April 2025 - March 2026)
• May 9 ·

  SeekingAlpha
  Biotech Outperformance - Can't Take What's Already Earned
• April 25 ·

  Yahoo
  European Growth Companies Insiders Are Eager To Own
• April 1 ·

  Yahoo
  The European Commission refers lecanemab decision to Appeal Committee
• January 14 ·

  Yahoo
  FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US